A recent study also identified a subset of tumor-initiating stem-like cells in human prostate cancer cell lines and xenografts based on co-expression of the human pluripotent stem cell marker TRA-1-60, CD151 and CD166 [49]. Here, ALCAM is linked to prostate carcinoma.